Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) EPS (Weighted Average and Diluted) (2024 - 2025)

Historic EPS (Weighted Average and Diluted) for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to -$0.64.

  • Kestra Medical Technologies' EPS (Weighted Average and Diluted) rose 4621.85% to -$0.64 in Q4 2025 from the same period last year, while for Oct 2025 it was -$3.96, marking a year-over-year increase of 1592.36%. This contributed to the annual value of -$5.13 for FY2025, which is 119.98% down from last year.
  • As of Q4 2025, Kestra Medical Technologies' EPS (Weighted Average and Diluted) stood at -$0.64, which was up 4621.85% from -$0.5 recorded in Q3 2025.
  • Kestra Medical Technologies' EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.5 during Q3 2025, with a 5-year trough of -$2.25 in Q2 2025.